Neurologists need to engage their emergency medicine colleagues to identify protocols and pathways for when to trigger appropriate neurological consultation or initiate acute stroke therapies.
According to a study published in Stroke artificially-sweetened beverages is associated with increased risk of stroke and dementia.
Compared with other sources of ICH, those associated with arteriovenous malformations had lower odds of death.
Intracranial atherosclerosis was lower in patients with migraine compared with those without migraine.
Dual therapy was associated with a significantly higher bleeding risk.
Delays in anticoagulation treatment resulted in increased risk for dementia.
No between-group differences were observed for reperfusion success and mortality, among other measures.
Neglecting abnormalities in ECG readings could result in serious acute cardiac events in patients presenting with stroke.
Intensive antiplatelet therapy appears to reduce risk of recurrence immediately after stroke, but may pose risks further out.
New research from the American Heart and American Stroke Associations found that many Americans don't know the symptoms of stroke.
Findings from a new study suggest that engaging in stroke prevention strategies may help reduce the risk of dementia.
Neurology Advisor Articles
- Serum Cytokine Levels May Correlate With Cognitive Dysfunction in Alzheimer's Disease
- Migraine-Associated Stroke Not Linked to Atherosclerosis
- Ptosis Repair Effective for Reducing Tension-Type Headache
- Intracranial Hemorrhage Associated with Arteriovenous Malformations Linked to Better Outcomes
- MRI-Guided Focused Ultrasound More Cost Effective Treatment for Essential Tremor
- In MS, Disease Duration, Lesion Load Predict Relapses and Disability Progression
- Stroke and Dementia Associated with Artificially-Sweetened Drinks?
- Case Report: DBS for the Treatment of Dystonia in Huntington's
- Treating Movement Disorders With Telemedicine: Getting Started
- Poor Quality of Sleep, Quality of Life in Patients With Lupus